| Min Pa: | Min Pa(max): | Activity's type: |
| Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |
|---|---|---|---|---|---|---|
| 0.94 | 0.004 | 0.95 | Cyclophilin D inhibitor | 0.932 0.004 DBMET01372 0.95 0.004 DBMET02424 0.903 0.005 DBMET02425 | DBMET02424 | |
| 0.889 | 0 | 0.908 | Sodium/glucose cotransporter inhibitor | 0.908 0 DBMET01372 0.726 0 DBMET02424 0.473 0.001 DBMET02425 | DBMET01372 | |
| 0.866 | 0 | 0.883 | Sodium/glucose cotransporter 2 inhibitor | 0.883 0 DBMET01372 0.681 0 DBMET02424 0.404 0.001 DBMET02425 | DBMET01372 | |
| 0.808 | 0.004 | 0.835 | Hypoglycemic | 0.835 0.004 DBMET01372 0.826 0.004 DBMET02424 0.69 0.005 DBMET02425 | DBMET01372 | |
| 0.748 | 0.005 | 0.882 | Cholesterol antagonist | 0.882 0.003 DBMET01372 0.705 0.008 DBMET02424 0.798 0.004 DBMET02425 | DBMET01372 | |
| 0.697 | 0.021 | 0.89 | Transcription factor NF kappa B inhibitor | 0.89 0.007 DBMET01372 0.717 0.019 DBMET02424 0.679 0.023 DBMET02425 | DBMET01372 | |
| 0.666 | 0.014 | 0.687 | Antiobesity | 0.55 0.028 DBMET01372 0.687 0.012 DBMET02424 0.674 0.013 DBMET02425 | DBMET02424 | |
| 0.598 | 0.004 | 0.757 | Amylase inhibitor | 0.757 0.002 DBMET01372 0.646 0.004 DBMET02424 0.445 0.007 DBMET02425 | DBMET01372 | |
| 0.569 | 0.009 | 0.64 | Vasodilator, coronary | 0.64 0.006 DBMET01372 0.495 0.016 DBMET02424 0.616 0.007 DBMET02425 | DBMET01372 | |
| 0.554 | 0.003 | 0.75 | AMP-activated protein kinase stimulant | 0.75 0.002 DBMET01372 0.622 0.003 DBMET02424 0.286 0.005 DBMET02425 | DBMET01372 | |
| 0.585 | 0.038 | 0.668 | Caspase 9 stimulant | 0.539 0.047 DBMET01372 0.668 0.028 DBMET02424 0.45 0.083 DBMET02425 | DBMET02424 | |
| 0.525 | 0.023 | 0.525 | 5 Hydroxytryptamine release stimulant | 0.504 0.027 DBMET01372 0.466 0.033 DBMET02424 0.45 0.036 DBMET02425 | ||
| 0.474 | 0.008 | 0.623 | Melanin inhibitor | 0.498 0.007 DBMET01372 0.623 0.004 DBMET02424 0.365 0.015 DBMET02425 | DBMET02424 | |
| 0.474 | 0.023 | 0.62 | Antioxidant | 0.62 0.01 DBMET01372 0.571 0.013 DBMET02424 0.447 0.027 DBMET02425 | DBMET01372 | |
| 0.45 | 0.004 | 0.454 | UDP-glucose 4-epimerase inhibitor | 0.454 0.004 DBMET01372 0.454 0.004 DBMET02424 0.44 0.004 DBMET02425 | DBMET02424 | |
| 0.458 | 0.036 | 0.751 | Antithrombotic | 0.751 0.006 DBMET01372 0.462 0.035 DBMET02424 0.537 0.024 DBMET02425 | DBMET01372 | |
| 0.446 | 0.028 | 0.556 | Apoptosis antagonist | 0.556 0.014 DBMET01372 0.509 0.019 DBMET02424 0.425 0.032 DBMET02425 | DBMET01372 | |
| 0.461 | 0.053 | 0.68 | Antibacterial | 0.68 0.01 DBMET01372 0.532 0.032 DBMET02424 0.446 0.058 DBMET02425 | DBMET01372 | |
| 0.452 | 0.049 | 0.671 | Histamine release inhibitor | 0.671 0.005 DBMET01372 0.439 0.055 DBMET02424 0.49 0.032 DBMET02425 | DBMET01372 | |
| 0.477 | 0.087 | 0.659 | Alpha-glucosidase inhibitor | 0.659 0.041 DBMET01372 0.483 0.085 DBMET02424 0.408 0.111 DBMET02425 | DBMET01372 | |
| 0.407 | 0.028 | 0.551 | Free radical scavenger | 0.551 0.012 DBMET01372 0.509 0.015 DBMET02424 0.355 0.038 DBMET02425 | DBMET01372 | |
| 0.395 | 0.026 | 0.482 | Hypolipemic | 0.411 0.023 DBMET01372 0.38 0.029 DBMET02424 0.482 0.014 DBMET02425 | DBMET02425 | |
| 0.379 | 0.014 | 0.473 | Platelet adhesion inhibitor | 0.473 0.006 DBMET01372 0.405 0.011 DBMET02424 0.381 0.014 DBMET02425 | DBMET01372 | |
| 0.382 | 0.032 | 0.382 | Calcium channel activator | 0.341 0.056 DBMET02424 0.227 0.175 DBMET02425 | ||
| 0.439 | 0.096 | 0.593 | Apoptosis agonist | 0.593 0.05 DBMET01372 0.498 0.075 DBMET02424 0.378 0.125 DBMET02425 | DBMET01372 | |
| 0.343 | 0.01 | 0.343 | Insulin sensitizer | 0.266 0.026 DBMET01372 0.268 0.026 DBMET02424 0.225 0.051 DBMET02425 | ||
| 0.338 | 0.013 | 0.44 | NOS3 expression enhancer | 0.334 0.013 DBMET01372 0.44 0.006 DBMET02424 0.292 0.019 DBMET02425 | DBMET02424 | |
| 0.354 | 0.031 | 0.609 | Angiogenesis stimulant | 0.609 0.006 DBMET01372 0.384 0.024 DBMET02424 0.337 0.036 DBMET02425 | DBMET01372 | |
| 0.345 | 0.025 | 0.438 | RNA-directed DNA polymerase inhibitor | 0.264 0.042 DBMET01372 0.438 0.015 DBMET02424 0.256 0.046 DBMET02425 | DBMET02424 | |
| 0.347 | 0.031 | 0.404 | DNA synthesis inhibitor | 0.392 0.023 DBMET01372 0.404 0.021 DBMET02424 0.335 0.034 DBMET02425 | DBMET02424 | |
| 0.371 | 0.058 | 0.562 | Immunostimulant | 0.562 0.021 DBMET01372 0.406 0.048 DBMET02424 0.329 0.071 DBMET02425 | DBMET01372 | |
| 0.33 | 0.022 | 0.471 | Hepatoprotectant | 0.471 0.008 DBMET01372 0.367 0.017 DBMET02424 0.321 0.024 DBMET02425 | DBMET01372 | |
| 0.319 | 0.017 | 0.378 | Interferon gamma antagonist | 0.358 0.013 DBMET01372 0.378 0.012 DBMET02424 0.25 0.028 DBMET02425 | DBMET02424 | |
| 0.348 | 0.047 | 0.39 | Interleukin 2 agonist | 0.389 0.03 DBMET01372 0.39 0.03 DBMET02424 0.337 0.052 DBMET02425 | DBMET02424 | |
| 0.307 | 0.011 | 0.311 | Aldehyde dehydrogenase inhibitor | 0.207 0.026 DBMET01372 0.3 0.012 DBMET02424 0.311 0.011 DBMET02425 | DBMET02425 | |
| 0.306 | 0.012 | 0.379 | Insulin secretagoues | 0.379 0.007 DBMET01372 0.27 0.016 DBMET02424 0.195 0.038 DBMET02425 | DBMET01372 | |
| 0.366 | 0.078 | 0.493 | Immunosuppressant | 0.493 0.035 DBMET01372 0.38 0.072 DBMET02424 0.376 0.074 DBMET02425 | DBMET01372 | |
| 0.337 | 0.05 | 0.393 | Hypoxia-inducible factor 1 alpha inhibitor | 0.325 0.054 DBMET01372 0.393 0.032 DBMET02424 0.215 0.135 DBMET02425 | DBMET02424 | |
| 0.38 | 0.095 | 0.436 | Calcium channel L-type activator | 0.284 0.171 DBMET01372 0.436 0.058 DBMET02424 | DBMET02424 | |
| 0.299 | 0.018 | 0.492 | Monophenol monooxygenase inhibitor | 0.492 0.008 DBMET01372 0.373 0.013 DBMET02424 0.181 0.038 DBMET02425 | DBMET01372 | |
| 0.299 | 0.018 | 0.396 | Neurotrophic factor enhancer | 0.246 0.04 DBMET01372 0.396 0.006 DBMET02424 0.212 0.066 DBMET02425 | DBMET02424 | |
| 0.273 | 0.02 | 0.273 | Nitric-oxide synthase stimulant | 0.266 0.023 DBMET01372 0.251 0.031 DBMET02424 0.259 0.027 DBMET02425 | ||
| 0.288 | 0.043 | 0.405 | Nitric oxide antagonist | 0.405 0.025 DBMET01372 0.347 0.032 DBMET02424 0.288 0.043 DBMET02425 | DBMET01372 | |
| 0.39 | 0.145 | 0.679 | Antiinflammatory | 0.679 0.035 DBMET01372 0.492 0.091 DBMET02424 0.514 0.082 DBMET02425 | DBMET01372 | |
| 0.266 | 0.023 | 0.349 | Protein kinase stimulant | 0.273 0.021 DBMET01372 0.349 0.012 DBMET02424 0.121 0.091 DBMET02425 | DBMET02424 | |
| 0.25 | 0.008 | 0.378 | Selectin antagonist | 0.378 0.004 DBMET01372 0.285 0.006 DBMET02424 0.227 0.009 DBMET02425 | DBMET01372 | |
| 0.288 | 0.047 | 0.319 | Cyclic AMP phosphodiesterase inhibitor | 0.319 0.035 DBMET01372 0.24 0.069 DBMET02424 0.314 0.037 DBMET02425 | DBMET01372 | |
| 0.322 | 0.086 | 0.322 | Vasodilator, peripheral | 0.222 0.152 DBMET01372 0.292 0.101 DBMET02424 0.266 0.116 DBMET02425 | ||
| 0.234 | 0.004 | 0.342 | Phosphorylase inhibitor | 0.209 0.005 DBMET01372 0.342 0.003 DBMET02424 0.151 0.007 DBMET02425 | DBMET02424 | |
| 0.239 | 0.016 | 0.296 | ATPase inhibitor | 0.296 0.006 DBMET01372 0.249 0.014 DBMET02424 0.198 0.039 DBMET02425 | DBMET01372 | |
| 0.279 | 0.062 | 0.4 | Tumour necrosis factor alpha release inhibitor | 0.4 0.027 DBMET01372 0.264 0.069 DBMET02424 0.158 0.148 DBMET02425 | DBMET01372 | |
| 0.289 | 0.088 | 0.457 | Immunomodulator | 0.457 0.03 DBMET01372 0.308 0.078 DBMET02424 0.287 0.09 DBMET02425 | DBMET01372 | |
| 0.246 | 0.052 | 0.246 | Anesthetic general | 0.201 0.074 DBMET01372 0.194 0.078 DBMET02424 | ||
| 0.207 | 0.013 | 0.27 | Potassium channel (Ca-activated) activator | 0.27 0.006 DBMET02424 0.134 0.034 DBMET02425 | DBMET02424 | |
| 0.279 | 0.091 | 0.333 | Caspase 3 stimulant | 0.333 0.065 DBMET01372 0.317 0.071 DBMET02424 0.213 0.152 DBMET02425 | DBMET01372 | |
| 0.203 | 0.018 | 0.378 | Cyclooxygenase 3 inhibitor | 0.378 0.004 DBMET01372 0.217 0.014 DBMET02424 0.168 0.035 DBMET02425 | DBMET01372 | |
| 0.203 | 0.02 | 0.376 | Expectorant | 0.376 0.005 DBMET01372 0.204 0.019 DBMET02424 0.13 0.044 DBMET02425 | DBMET01372 | |
| 0.206 | 0.026 | 0.243 | DNA polymerase I inhibitor | 0.174 0.038 DBMET01372 0.243 0.018 DBMET02424 0.198 0.029 DBMET02425 | DBMET02424 | |
| 0.248 | 0.07 | 0.303 | Vasodilator | 0.303 0.047 DBMET01372 0.233 0.08 DBMET02424 0.206 0.1 DBMET02425 | DBMET01372 | |
| 0.209 | 0.032 | 0.24 | Alpha-N-acetylglucosaminidase inhibitor | 0.194 0.036 DBMET01372 0.24 0.025 DBMET02424 0.193 0.036 DBMET02425 | DBMET02424 | |
| 0.234 | 0.058 | 0.252 | DNA methylase inhibitor | 0.252 0.047 DBMET01372 0.247 0.05 DBMET02424 | DBMET01372 | |
| 0.236 | 0.061 | 0.362 | Peptidyltransferase inhibitor | 0.362 0.01 DBMET01372 0.258 0.045 DBMET02424 0.228 0.068 DBMET02425 | DBMET01372 | |
| 0.251 | 0.078 | 0.307 | Interleukin agonist | 0.307 0.045 DBMET01372 0.238 0.088 DBMET02424 0.219 0.103 DBMET02425 | DBMET01372 | |
| 0.248 | 0.081 | 0.317 | DNA damaging | 0.259 0.076 DBMET01372 0.317 0.051 DBMET02424 | DBMET02424 | |
| 0.221 | 0.057 | 0.272 | Glyceraldehyde-3-phosphate dehydrogenase inhibitor | 0.272 0.033 DBMET02424 0.201 0.071 DBMET02425 | DBMET02424 | |
| 0.191 | 0.029 | 0.191 | Cholesterol synthesis inhibitor | 0.122 0.063 DBMET01372 0.186 0.03 DBMET02424 0.158 0.041 DBMET02425 | ||
| 0.202 | 0.043 | 0.267 | Phospholipase C inhibitor | 0.267 0.022 DBMET02424 | DBMET02424 | |
| 0.177 | 0.021 | 0.235 | Carbonic anhydrase III inhibitor | 0.124 0.042 DBMET01372 0.235 0.011 DBMET02424 0.152 0.028 DBMET02425 | DBMET02424 | |
| 0.185 | 0.029 | 0.352 | Cell adhesion inhibitor | 0.352 0.007 DBMET01372 0.202 0.024 DBMET02424 0.18 0.031 DBMET02425 | DBMET01372 | |
| 0.198 | 0.042 | 0.223 | Interleukin 6 antagonist | 0.223 0.03 DBMET01372 0.22 0.031 DBMET02424 | DBMET01372 | |
| 0.214 | 0.062 | 0.226 | DNA methyltransferase I inhibitor | 0.226 0.057 DBMET01372 0.225 0.057 DBMET02424 | DBMET01372 | |
| 0.159 | 0.016 | 0.17 | Toll-Like receptor 4 antagonist | 0.17 0.013 DBMET01372 0.163 0.015 DBMET02424 0.147 0.023 DBMET02425 | DBMET01372 | |
| 0.157 | 0.016 | 0.224 | NADH dehydrogenase inhibitor | 0.154 0.017 DBMET01372 0.224 0.009 DBMET02424 0.153 0.017 DBMET02425 | DBMET02424 | |
| 0.19 | 0.052 | 0.19 | Cytidine deaminase inhibitor | 0.16 0.069 DBMET02424 | ||
| 0.155 | 0.021 | 0.196 | Carbonic anhydrase XIII inhibitor | 0.107 0.035 DBMET01372 0.196 0.014 DBMET02424 0.122 0.029 DBMET02425 | DBMET02424 | |
| 0.151 | 0.019 | 0.151 | Aminoacyl-tRNA synthetase inhibitor | 0.09 0.058 DBMET01372 0.135 0.024 DBMET02424 0.138 0.023 DBMET02425 | ||
| 0.153 | 0.022 | 0.196 | Uric acid excretion stimulant | 0.196 0.014 DBMET01372 0.191 0.014 DBMET02424 0.167 0.019 DBMET02425 | DBMET01372 | |
| 0.149 | 0.02 | 0.186 | Triose-phosphate isomerase inhibitor | 0.152 0.019 DBMET01372 0.186 0.013 DBMET02424 0.101 0.047 DBMET02425 | DBMET02424 | |
| 0.2 | 0.071 | 0.393 | Non-steroidal antiinflammatory agent | 0.393 0.014 DBMET01372 0.211 0.063 DBMET02424 | DBMET01372 | |
| 0.149 | 0.021 | 0.219 | Carbonic anhydrase VI inhibitor | 0.096 0.042 DBMET01372 0.219 0.011 DBMET02424 | DBMET02424 | |
| 0.174 | 0.053 | 0.258 | Lipid peroxidase inhibitor | 0.258 0.025 DBMET01372 0.211 0.037 DBMET02424 0.167 0.057 DBMET02425 | DBMET01372 | |
| 0.15 | 0.032 | 0.202 | DNA repair enzyme inhibitor | 0.202 0.009 DBMET01372 0.163 0.022 DBMET02424 | DBMET01372 | |
| 0.151 | 0.034 | 0.245 | Xanthine oxidase inhibitor | 0.245 0.013 DBMET01372 0.184 0.023 DBMET02424 0.11 0.053 DBMET02425 | DBMET01372 | |
| 0.142 | 0.029 | 0.182 | UDP-N-acetylglucosamine 1-carboxyvinyltransferase inhibitor | 0.118 0.04 DBMET01372 0.182 0.019 DBMET02424 0.124 0.037 DBMET02425 | DBMET02424 | |
| 0.148 | 0.042 | 0.289 | Cystathionine beta-synthase inhibitor | 0.11 0.066 DBMET01372 0.289 0.011 DBMET02424 | DBMET02424 | |
| 0.125 | 0.021 | 0.14 | Phosphodiesterase 6D inhibitor | 0.14 0.013 DBMET01372 0.101 0.05 DBMET02424 0.099 0.054 DBMET02425 | DBMET01372 | |
| 0.149 | 0.048 | 0.163 | Heat shock protein 70 antagonist | 0.163 0.024 DBMET02424 | DBMET02424 | |
| 0.21 | 0.112 | 0.428 | Spasmolytic | 0.265 0.085 DBMET01372 0.181 0.136 DBMET02424 0.428 0.035 DBMET02425 | DBMET02425 | |
| 0.141 | 0.043 | 0.153 | Microtubule formation inhibitor | 0.142 0.042 DBMET01372 0.153 0.036 DBMET02424 | DBMET02424 | |
| 0.164 | 0.066 | 0.179 | Protein-tyrosine phosphatase inhibitor | 0.172 0.061 DBMET01372 0.179 0.057 DBMET02424 0.137 0.093 DBMET02425 | DBMET02424 | |
| 0.184 | 0.087 | 0.275 | Amyloid beta aggregation inhibitor | 0.275 0.05 DBMET02424 | DBMET02424 | |
| 0.147 | 0.053 | 0.184 | Interleukin 4 antagonist | 0.141 0.059 DBMET01372 0.184 0.028 DBMET02424 0.132 0.069 DBMET02425 | DBMET02424 | |
| 0.146 | 0.053 | 0.146 | Ca2+-transporting ATPase inhibitor | 0.146 0.053 DBMET01372 0.144 0.058 DBMET02424 0.142 0.067 DBMET02425 | ||
| 0.154 | 0.061 | 0.154 | Mannose-6-phosphate isomerase inhibitor | 0.114 0.113 DBMET01372 0.147 0.067 DBMET02424 0.144 0.069 DBMET02425 | ||
| 0.137 | 0.052 | 0.159 | Protein-tyrosine phosphatase 1B inhibitor | 0.159 0.042 DBMET01372 0.151 0.045 DBMET02424 0.111 0.069 DBMET02425 | DBMET01372 | |
| 0.16 | 0.075 | 0.335 | Thrombolytic | 0.269 0.029 DBMET01372 0.175 0.065 DBMET02424 0.335 0.019 DBMET02425 | DBMET02425 | |
| 0.1 | 0.017 | 0.141 | 3-Oxoacyl-[acyl-carrier-protein] synthase inhibitor | 0.108 0.015 DBMET01372 0.141 0.008 DBMET02424 0.053 0.048 DBMET02425 | DBMET02424 | |
| 0.111 | 0.028 | 0.194 | Cell adhesion molecule inhibitor | 0.194 0.01 DBMET01372 0.116 0.025 DBMET02424 0.129 0.02 DBMET02425 | DBMET01372 | |
| 0.104 | 0.022 | 0.138 | Potassium channel large-conductance Ca-activated activator | 0.063 0.054 DBMET01372 0.138 0.013 DBMET02424 0.08 0.035 DBMET02425 | DBMET02424 | |
| 0.148 | 0.066 | 0.159 | Adenylate cyclase stimulant | 0.159 0.049 DBMET02424 0.125 0.114 DBMET02425 | DBMET02424 | |
| 0.083 | 0.003 | 0.083 | Uridine phosphorylase inhibitor | 0.062 0.005 DBMET01372 0.062 0.005 DBMET02424 0.039 0.013 DBMET02425 | ||
| 0.135 | 0.056 | 0.169 | Adenylate cyclase inhibitor | 0.169 0.034 DBMET02424 | DBMET02424 | |
| 0.189 | 0.11 | 0.283 | Platelet antagonist | 0.283 0.059 DBMET01372 0.168 0.127 DBMET02424 0.28 0.06 DBMET02425 | DBMET01372 | |
| 0.187 | 0.109 | 0.278 | Antiamyloidogenic | 0.255 0.069 DBMET01372 0.278 0.059 DBMET02424 0.16 0.134 DBMET02425 | DBMET02424 | |
| 0.126 | 0.052 | 0.192 | Topoisomerase I inhibitor | 0.192 0.028 DBMET01372 0.182 0.031 DBMET02424 0.109 0.063 DBMET02425 | DBMET01372 | |
| 0.106 | 0.034 | 0.157 | Transcription factor NF kappa B stimulant | 0.157 0.014 DBMET01372 0.099 0.04 DBMET02424 0.102 0.037 DBMET02425 | DBMET01372 | |
| 0.085 | 0.013 | 0.11 | Glucosylceramidase inhibitor | 0.082 0.014 DBMET02424 0.11 0.006 DBMET02425 | DBMET02425 | |
| 0.13 | 0.059 | 0.191 | Alkylator | 0.191 0.029 DBMET01372 0.176 0.034 DBMET02424 0.112 0.076 DBMET02425 | DBMET01372 | |
| 0.145 | 0.074 | 0.392 | Hemostatic | 0.392 0.008 DBMET01372 0.177 0.044 DBMET02424 | DBMET01372 | |
| 0.121 | 0.054 | 0.15 | Estrogen antagonist | 0.1 0.099 DBMET01372 0.15 0.023 DBMET02424 0.119 0.057 DBMET02425 | DBMET02424 | |
| 0.107 | 0.041 | 0.118 | Thioredoxin inhibitor | 0.105 0.043 DBMET01372 0.118 0.032 DBMET02424 0.1 0.048 DBMET02425 | DBMET02424 | |
| 0.115 | 0.051 | 0.177 | Beta glucuronidase inhibitor | 0.177 0.016 DBMET01372 0.155 0.023 DBMET02424 0.097 0.075 DBMET02425 | DBMET01372 | |
| 0.18 | 0.116 | 0.18 | Aldehyde oxidase inhibitor | 0.167 0.125 DBMET02424 | ||
| 0.108 | 0.044 | 0.123 | Alcohol dehydrogenase inhibitor | 0.123 0.033 DBMET01372 0.118 0.036 DBMET02424 | DBMET01372 | |
| 0.1 | 0.043 | 0.125 | Glutamate release inhibitor | 0.125 0.019 DBMET01372 0.098 0.046 DBMET02424 0.085 0.075 DBMET02425 | DBMET01372 | |
| 0.092 | 0.039 | 0.115 | Na+ K+ transporting ATPase inhibitor | 0.098 0.034 DBMET01372 0.103 0.029 DBMET02424 0.115 0.019 DBMET02425 | DBMET02425 | |
| 0.088 | 0.037 | 0.141 | Phosphofructokinase-1 inhibitor | 0.137 0.021 DBMET01372 0.141 0.02 DBMET02424 0.074 0.044 DBMET02425 | DBMET02424 | |
| 0.102 | 0.052 | 0.121 | Lanosterol 14 alpha demethylase inhibitor | 0.121 0.029 DBMET02424 | DBMET02424 | |
| 0.107 | 0.058 | 0.111 | Carbonic anhydrase XV inhibitor | 0.111 0.054 DBMET02424 0.098 0.07 DBMET02425 | DBMET02424 | |
| 0.066 | 0.02 | 0.081 | Alpha-mannosidase inhibitor | 0.068 0.018 DBMET01372 0.081 0.011 DBMET02424 0.058 0.03 DBMET02425 | DBMET02424 | |
| 0.094 | 0.049 | 0.107 | ATPase (Vacuolar H+) inhibitor | 0.107 0.03 DBMET01372 0.084 0.068 DBMET02424 0.089 0.059 DBMET02425 | DBMET01372 | |
| 0.11 | 0.065 | 0.112 | Mucolytic | 0.112 0.063 DBMET01372 0.108 0.067 DBMET02424 0.095 0.085 DBMET02425 | DBMET01372 | |
| 0.063 | 0.018 | 0.063 | Squalene epoxidase inhibitor | 0.058 0.023 DBMET02424 | ||
| 0.053 | 0.011 | 0.085 | Antibiotic Aminoglycoside-like | 0.085 0.004 DBMET01372 0.059 0.009 DBMET02424 0.053 0.012 DBMET02425 | DBMET01372 | |
| 0.092 | 0.05 | 0.186 | Antineoplastic antibiotic | 0.186 0.023 DBMET01372 0.125 0.037 DBMET02424 0.09 0.051 DBMET02425 | DBMET01372 | |
| 0.072 | 0.033 | 0.072 | MDM2 inhibitor | |||
| 0.085 | 0.047 | 0.126 | NAD(P)H dehydrogenase (quinone) inhibitor | 0.126 0.027 DBMET02424 | DBMET02424 | |
| 0.056 | 0.019 | 0.071 | Mannosidase inhibitor | 0.062 0.015 DBMET01372 0.071 0.011 DBMET02424 0.048 0.028 DBMET02425 | DBMET02424 | |
| 0.056 | 0.022 | 0.068 | Glucose-6-phosphate isomerase inhibitor | 0.047 0.035 DBMET01372 0.068 0.014 DBMET02424 0.052 0.027 DBMET02425 | DBMET02424 | |
| 0.15 | 0.117 | 0.154 | P-glycoprotein inhibitor | 0.154 0.111 DBMET01372 | DBMET01372 | |
| 0.058 | 0.027 | 0.133 | Heparanase inhibitor | 0.133 0.003 DBMET01372 0.058 0.027 DBMET02424 0.052 0.041 DBMET02425 | DBMET01372 | |
| 0.132 | 0.101 | 0.193 | Hexokinase inhibitor | 0.152 0.077 DBMET01372 0.193 0.04 DBMET02424 | DBMET02424 | |
| 0.033 | 0.004 | 0.033 | Isoleucine-tRNA ligase inhibitor | 0.025 0.01 DBMET02424 0.029 0.005 DBMET02425 | ||
| 0.083 | 0.055 | 0.088 | Thioredoxin reductase inhibitor | 0.088 0.045 DBMET02424 0.078 0.067 DBMET02425 | DBMET02424 | |
| 0.042 | 0.015 | 0.042 | Ceramide glucosyltransferase inhibitor | 0.042 0.014 DBMET02424 0.037 0.022 DBMET02425 | ||
| 0.061 | 0.034 | 0.061 | Mannitol-1-phosphate 5-dehydrogenase inhibitor | 0.061 0.033 DBMET02424 0.059 0.035 DBMET02425 | ||
| 0.052 | 0.028 | 0.053 | Adenosine deaminase inhibitor | 0.053 0.027 DBMET02424 0.044 0.036 DBMET02425 | DBMET02424 | |
| 0.117 | 0.094 | 0.125 | Vanilloid 1 agonist | 0.118 0.092 DBMET01372 0.125 0.077 DBMET02424 | DBMET02424 | |
| 0.055 | 0.032 | 0.109 | Estrogen agonist | 0.055 0.033 DBMET01372 0.109 0.015 DBMET02424 | DBMET02424 | |
| 0.085 | 0.063 | 0.085 | Interleukin 5 antagonist | 0.085 0.063 DBMET01372 0.083 0.066 DBMET02424 | ||
| 0.052 | 0.03 | 0.069 | Antimetabolite | 0.069 0.022 DBMET02424 | DBMET02424 | |
| 0.119 | 0.1 | 0.264 | Cell wall synthesis inhibitor | 0.264 0.014 DBMET01372 0.172 0.046 DBMET02424 | DBMET01372 | |
| 0.069 | 0.05 | 0.098 | HIV-1 integrase inhibitor | 0.098 0.026 DBMET02424 | DBMET02424 | |
| 0.19 | 0.172 | 0.263 | 5 Hydroxytryptamine uptake stimulant | 0.263 0.069 DBMET02424 | DBMET02424 | |
| 0.03 | 0.012 | 0.033 | Adenosine A1 receptor agonist | 0.021 0.02 DBMET01372 0.033 0.01 DBMET02424 0.029 0.012 DBMET02425 | DBMET02424 | |
| 0.071 | 0.053 | 0.092 | Lipase inhibitor | 0.077 0.046 DBMET01372 0.092 0.032 DBMET02424 | DBMET02424 | |
| 0.154 | 0.137 | 0.154 | MAP kinase kinase 5 inhibitor | |||
| 0.089 | 0.074 | 0.107 | Sphingomyelinase inhibitor | 0.107 0.052 DBMET02425 | DBMET02425 | |
| 0.036 | 0.023 | 0.06 | Phosphoglycerate kinase inhibitor | 0.06 0.011 DBMET02424 0.032 0.028 DBMET02425 | DBMET02424 | |
| 0.11 | 0.099 | 0.141 | Alkaline phosphatase inhibitor | 0.141 0.066 DBMET01372 0.115 0.092 DBMET02424 | DBMET01372 | |
| 0.091 | 0.081 | 0.12 | Estrogen receptor beta antagonist | 0.12 0.032 DBMET02424 | DBMET02424 | |
| 0.126 | 0.117 | 0.154 | Arachidonic acid antagonist | 0.132 0.11 DBMET02424 0.154 0.083 DBMET02425 | DBMET02425 | |
| 0.031 | 0.023 | 0.136 | Squalene synthetase inhibitor | 0.043 0.017 DBMET01372 0.029 0.025 DBMET02424 0.136 0.004 DBMET02425 | DBMET02425 | |
| 0.026 | 0.018 | 0.031 | Thymidine phosphorylase inhibitor | 0.031 0.011 DBMET02424 | DBMET02424 | |
| 0.022 | 0.015 | 0.031 | Adenosine kinase inhibitor | 0.031 0.01 DBMET02424 | DBMET02424 | |
| 0.024 | 0.017 | 0.064 | Protein 30S ribosomal subunit inhibitor | 0.064 0.005 DBMET01372 0.029 0.013 DBMET02424 0.023 0.018 DBMET02425 | DBMET01372 | |
| 0.02 | 0.014 | 0.024 | Inosine monophosphate dehydrogenase 1 inhibitor | 0.024 0.011 DBMET02424 0.019 0.015 DBMET02425 | DBMET02424 | |
| 0.058 | 0.052 | 0.067 | Nitric oxide donor | 0.067 0.037 DBMET01372 | DBMET01372 | |
| 0.034 | 0.028 | 0.054 | Inosine monophosphate dehydrogenase inhibitor | 0.054 0.013 DBMET02424 | DBMET02424 | |
| 0.012 | 0.008 | 0.015 | Purine nucleoside phosphorylase inhibitor | 0.015 0.005 DBMET02424 | DBMET02424 | |
| 0.03 | 0.026 | 0.082 | Estrogen receptor alpha agonist | 0.082 0.011 DBMET02424 | DBMET02424 | |
| 0.046 | 0.043 | 0.077 | Aldose reductase inhibitor | 0.062 0.031 DBMET01372 0.077 0.024 DBMET02424 | DBMET02424 | |
| 0.059 | 0.057 | 0.063 | Leukotriene synthesis inhibitor | 0.063 0.051 DBMET02424 0.063 0.051 DBMET02425 | DBMET02425 | |
| 0.014 | 0.012 | 0.014 | Adenosine A2b receptor agonist | 0.014 0.01 DBMET02424 0.013 0.012 DBMET02425 | ||
| 0.026 | 0.026 | 0.029 | 1,3-Beta-glucan synthase inhibitor | 0.029 0.019 DBMET01372 0.029 0.017 DBMET02424 | DBMET02424 | |
| 0.017 | 0.02 | 0.026 | Prostaglandin EP2 agonist | 0.026 0.014 DBMET02425 | DBMET02425 | |
| 0.051 | 0.054 | 0.062 | Adenine nucleotide translocase inhibitor | 0.062 0.025 DBMET01372 0.053 0.046 DBMET02424 0.056 0.036 DBMET02425 | DBMET01372 | |
| 0.035 | 0.04 | 0.043 | Thymidine kinase inhibitor | 0.043 0.026 DBMET02424 | DBMET02424 | |
| 0.041 | 0.045 | 0.073 | Carbonic anhydrase XIV inhibitor | 0.07 0.02 DBMET01372 0.053 0.03 DBMET02424 0.073 0.019 DBMET02425 | DBMET02425 | |
| 0.008 | 0.013 | 0.01 | Purinergic P2Y2 agonist | 0.01 0.009 DBMET02424 | DBMET02424 | |
| 0.039 | 0.044 | 0.043 | Microtubule stabilization | 0.043 0.037 DBMET01372 0.043 0.038 DBMET02424 | DBMET02424 | |
| 0.047 | 0.054 | 0.08 | HIV-1 integrase (Strand Transfer) inhibitor | 0.08 0.031 DBMET02424 | DBMET02424 | |
| 0.052 | 0.059 | 0.06 | Lipocortins synthesis agonist | 0.06 0.036 DBMET01372 | DBMET01372 | |
| 0.043 | 0.049 | 0.094 | Protein 50S ribosomal subunit inhibitor | 0.094 0.015 DBMET01372 0.049 0.041 DBMET02424 | DBMET01372 | |
| 0.238 | 0.246 | 0.26 | 5 Hydroxytryptamine release inhibitor | 0.26 0.214 DBMET01372 | DBMET01372 | |
| 0.018 | 0.026 | 0.027 | Dopamine D1 agonist | 0.027 0.011 DBMET02424 | DBMET02424 | |
| 0.064 | 0.071 | 0.067 | Adenosine A3 receptor antagonist | 0.067 0.064 DBMET02425 | DBMET02425 | |
| 0.082 | 0.091 | 0.151 | Mediator release inhibitor | 0.114 0.054 DBMET01372 0.151 0.028 DBMET02425 | DBMET02425 | |
| 0.023 | 0.033 | 0.031 | Toll-Like receptor 4 agonist | 0.031 0.01 DBMET01372 | DBMET01372 | |
| 0.036 | 0.048 | 0.046 | CF transmembrane conductance regulator antagonist | 0.046 0.013 DBMET02424 | DBMET02424 | |
| 0.077 | 0.091 | 0.087 | DNA directed RNA polymerase inhibitor | 0.087 0.073 DBMET02424 | DBMET02424 | |
| 0.012 | 0.028 | 0.016 | Telomerase stimulant | 0.016 0.014 DBMET02424 | DBMET02424 | |
| 0.06 | 0.076 | 0.077 | Glutamate dehydrogenase inhibitor | 0.077 0.048 DBMET02424 | DBMET02424 | |
| 0.021 | 0.039 | 0.029 | Prostaglandin agonist | 0.029 0.024 DBMET02425 | DBMET02425 | |
| 0.013 | 0.038 | 0.079 | Estrogen receptor beta agonist | 0.079 0.015 DBMET02424 | DBMET02424 | |
| 0.108 | 0.134 | 0.143 | Phospholipase A2 inhibitor | 0.143 0.082 DBMET01372 | DBMET01372 | |
| 0.05 | 0.08 | 0.076 | Histidine decarboxylase inhibitor | 0.076 0.045 DBMET02424 | DBMET02424 | |
| 0.068 | 0.099 | 0.121 | HIV-1 integrase (Overall Integration) inhibitor | 0.121 0.039 DBMET02424 | DBMET02424 | |
| 0.051 | 0.083 | 0.066 | Neuraminidase (influenza) inhibitor | 0.066 0.041 DBMET01372 | DBMET01372 | |
| 0.044 | 0.078 | 0.065 | HIV-1 integrase (3'-Processing) inhibitor | 0.065 0.042 DBMET02424 | DBMET02424 | |
| 0.062 | 0.097 | 0.07 | Estrogen receptor alpha antagonist | 0.07 0.067 DBMET02424 | DBMET02424 | |
| 0.103 | 0.141 | 0.127 | Papain-like protease (SARS coronavirus) inhibitor | 0.127 0.066 DBMET02424 | DBMET02424 | |
| 0.031 | 0.071 | 0.042 | Neuraminidase (Influenza A) inhibitor | 0.042 0.039 DBMET01372 | DBMET01372 | |
| 0.082 | 0.124 | 0.105 | Cyclooxygenase 1 inhibitor | 0.105 0.094 DBMET02424 | DBMET02424 | |
| 0.037 | 0.081 | 0.061 | Glucose-6-phosphate translocase inhibitor | 0.061 0.023 DBMET01372 | DBMET01372 | |
| 0.019 | 0.064 | 0.036 | ATP citrate lysase inhibitor | 0.036 0.016 DBMET02424 | DBMET02424 | |
| 0.067 | 0.113 | 0.137 | Creatine kinase inhibitor | 0.137 0.03 DBMET02424 | DBMET02424 | |
| 0.042 | 0.096 | 0.066 | Transcription factor AP-1 inhibitor | 0.066 0.036 DBMET02425 | DBMET02425 | |
| 0.05 | 0.109 | 0.065 | Beta 2 adrenoreceptor agonist | 0.065 0.032 DBMET02425 | DBMET02425 | |
| 0.04 | 0.1 | 0.065 | Purinergic P2X1 antagonist | 0.065 0.037 DBMET02424 | DBMET02424 | |
| 0.072 | 0.139 | 0.102 | Beta amyloid protein antagonist | 0.099 0.091 DBMET01372 0.102 0.086 DBMET02424 | DBMET02424 | |
| 0.008 | 0.087 | 0.031 | Arginase inhibitor | 0.031 0.03 DBMET01372 | DBMET01372 | |
| 0.088 | 0.17 | 0.149 | Diuretic | 0.149 0.078 DBMET01372 0.128 0.096 DBMET02425 | DBMET01372 | |
| 0.033 | 0.119 | 0.055 | Fatty acid synthase inhibitor | 0.055 0.042 DBMET02424 | DBMET02424 | |
| 0.059 | 0.147 | 0.197 | Topoisomerase II inhibitor | 0.197 0.034 DBMET01372 0.105 0.081 DBMET02424 | DBMET01372 | |
| 0.04 | 0.131 | 0.125 | Topoisomerase II alpha inhibitor | 0.125 0.028 DBMET01372 | DBMET01372 | |
| 0.048 | 0.139 | 0.073 | Glycine receptor antagonist | 0.073 0.07 DBMET02424 | DBMET02424 | |
| 0.031 | 0.136 | 0.085 | Adrenaline uptake inhibitor | 0.085 0.024 DBMET02425 | DBMET02425 | |
| 0.072 | 0.178 | 0.11 | NADPH oxidase inhibitor | 0.11 0.096 DBMET02424 | DBMET02424 | |
| 0.125 | 0.239 | 0.193 | Lipoxygenase inhibitor | 0.193 0.148 DBMET02425 | DBMET02425 | |
| 0.028 | 0.153 | 0.048 | Topoisomerase II beta inhibitor | 0.048 0.035 DBMET02424 | DBMET02424 | |
| 0.063 | 0.238 | 0.195 | Anticoagulant | 0.195 0.055 DBMET01372 | DBMET01372 | |
| 0.017 | 0.192 | 0.101 | Dopamine transporter inhibitor | 0.101 0.012 DBMET02425 | DBMET02425 | |
| 0.025 | 0.201 | 0.079 | Factor IXa inhibitor | 0.079 0.016 DBMET01372 0.061 0.026 DBMET02425 | DBMET01372 | |
| 0.033 | 0.262 | 0.092 | DNA intercalator | 0.092 0.083 DBMET01372 | DBMET01372 | |
| 0.095 | 0.333 | 0.133 | CC chemokine 6 receptor antagonist | 0.133 0.06 DBMET01372 | DBMET01372 | |
| 0.078 | 0.329 | 0.277 | Cardiotonic | 0.277 0.067 DBMET02425 | DBMET02425 | |
| 0.083 | 0.372 | 0.201 | Angiogenesis inhibitor | 0.201 0.168 DBMET01372 | DBMET01372 | |
| 0.008 | 0.317 | 0.055 | 5 Hydroxytryptamine uptake inhibitor | 0.055 0.051 DBMET02425 | DBMET02425 | |
| 0.049 | 0.617 | 0.135 | MAP kinase kinase 4 inhibitor | 0.135 0.098 DBMET02425 | DBMET02425 | |
| 0.005 | 0.732 | 0.109 | Check point kinase 2 inhibitor | 0.109 0.057 DBMET02425 | DBMET02425 | |
| 0.023 | 0.978 | 0.243 | MAP kinase kinase 3 inhibitor | 0.243 0.039 DBMET02425 | DBMET02425 | Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |